We can’t wait to connect with you at SITC2024!

If you are looking for a reliable partner for your drug development programs in immuno-oncology, we invite you to meet with the Veracyte Biopharma Services team at the Society for Immunotherapy of Cancer’s 39th Annual Meeting.

Veracyte can provide our biopharmaceutical partners with actionable insights to help advance their therapeutic discovery, development, and commercialization programs.

We look forward to meeting you and discussing how we can collaborate to shape the future of immuno-oncology.